U.S. venture investments in cardiovascular companies from 2006 to 2017
Venture investments in cardiovascular companies in the U.S. from 2006 to 2017 (in million U.S. dollars)
This graph shows the total venture investments in cardiovascular companies in the U.S. from 2006 to 2017, in million U.S. dollars. In 2015, venture investments in cardiovascular companies totaled approximately 245 million dollars.
Venture investments in cardiovascular companies in the U.S. from 2006 to 2017 (in million U.S. dollars)
Loading statistic...
| Venture investments in million U.S. dollars | |
|---|---|
| 2017 | 127 |
| 2016 | 51 |
| 2015 | 245 |
| 2014 | 56 |
| 2013 | 177 |
| 2012 | 283 |
| 2011 | 256 |
| 2010 | 141 |
| 2009 | 167 |
| 2008 | 221 |
| 2007* | 374 |
| 2006* | 299 |
Source
More information
Statistics on "Cardiovascular disease in the U.S."
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- U.S. number of venture capital deals for cardiovascular companies 2006-2017
- Cardiovascular conditions in Spain 2018, by age group
- Cardiovascular conditions in Spain 2018, by gender and age
- U.S. venture investments in psychiatry companies from 2006 to 2017
- U.S. number of venture capital deals for psychiatry companies 2006-2017
- U.S. number of venture capital deals for neurology companies 2006-2017
- U.S. number of venture capital deals for oncology companies 2006-2017
- U.S. number of venture capital deals for infectious disease companies 2006-2017
- U.S. venture investments in infectious disease companies from 2006 to 2017
- U.S. venture investments in neurology companies from 2006 to 2017
- U.S. cardiovascular company IPOs 2006-2017
- U.S. venture funding of therapeutic companies by disease type 2017
- U.S. cardiovascular company IPO financing volume 2006-2017
- Drug production value of cardiovascular agents Japan 2016, by category
- Top U.S. cholesterol-lowering drugs based on revenue 2013
- Production value of cardiovascular-renal drugs in Taiwan 2008-2017
- Cardiovascular system pharmaceutical consumption in Luxembourg 2005-2016
- DALYs among women in India by cardiovascular diseases 2016
- Value of the cardiac assist devices market South Korea 2007-2021
- Cardiovascular system pharmaceutical consumption in Sweden 2005-2017
Statistics on "Cardiovascular disease in the U.S."
Related topics
About Statista
